Photo courtesy: The Indian Express
New Delhi: Countries like France, Italy and Belgium have asked the hospitals here to stop the use of anti-malaria drug Hydroxychloroquine to treat COVID-19 patients.
The medication was halted amid health safety of the infected patients.
The World Health Organization (WHO) also paused trials of the drug after a report published in the Lancet Journal claimed the medication was harming the patients.
Following the health body’s instructions, the three hardest-hit countries by the coronavirus cancelled the authorization of the drug.
Meanwhile, the countries will continue to carry out clinical trials of the drug outside human use. The trials will also expose the potential risks of using the drug and check its effectiveness in treating the virus.
Also Read: Anti-Malarial Drug Hydroxychloroquine Increases Risk Of Corona Deaths In US: Study
Cuttack: A promising youthful life ended in Cuttack on Sunday as a sophomore was electrocuted…
Mumbai: Ever since ‘Kantara’ became a phenomenal hit in 2022, movie lovers have been yearning…
Bhubaneswar: The husband of a sarpanch and a panchayat samiti member were critically injured as…
New Delhi: Pollution in the national Capital is going from bad to worse. As Delhi’s air…
Bhubaneswar: In order to streamline the road construction works, the Odisha government is planning to…
Patna: The trailer of ‘Pushpa 2: The Rule’, one of the year’s most anticipated films, is…
Patna: It was one of the most anticipated events in the Indian film industry -- the…
Bhubaneswar: With Odisha government taking a serious note of unnatural death of elephants, the Forest…